BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Insmed Inc. (INSM) on Thursday reported a loss of $160.1 million in its fourth quarter.
On a per-share basis, the Bridgewater, New Jersey-based company said it had a loss of $1.21. Losses, adjusted for non-recurring costs, were $1.20 per share.
The results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1 per share.
The biopharmaceutical developing inhaled treatments for patients battling rare lung diseases posted revenue of $59.3 million in the period, which also missed Street forecasts. Five analysts surveyed by Zacks expected $65.8 million.
For the year, the company reported that its loss widened to $481.5 million, or $3.91 per share. Revenue was reported as $245.4 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INSM at https://www.zacks.com/ap/INSM
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.